Analyst Research: The Medicines Co (MDCO.O)
MDCO.O on Nasdaq
8.54USD
4:00pm EST
8.54USD
4:00pm EST
Price Change (% chg)
$0.15 (+1.79%)
$0.15 (+1.79%)
Prev Close
$8.39
$8.39
Open
$8.40
$8.40
Day's High
$8.57
$8.57
Day's Low
$8.30
$8.30
Volume
188,866
188,866
Avg. Vol
358,203
358,203
52-wk High
$16.77
$16.77
52-wk Low
$6.15
$6.15
| Name | Age | Since | Current Position |
|---|---|---|---|
| Meanwell, Clive | 51 | 2009 | Chairman of the Board, Chief Executive Officer |
| Sblendorio, Glenn | 53 | 2006 | Chief Financial Officer, Executive Vice President |
| Antinori, Paul | 55 | 2006 | Senior Vice President, General Counsel |
| Johnson, T. Scott | 61 | 2009 | Vice President - New Business Ventures, Chief Medical Advisor |
| O'Connor, William | 50 | Chief Accounting Officer |
- Medicines Co. blood thinner still has hope: doctors
- CORRECTED - CORRECTED-BUY OR SELL-Will Angiomax generics clot Medicines' sal
- HEADLINE STOCKS-Some U.S. stocks on the move on Aug. 31
- BEFORE THE BELL-Medicines up after comments on drug
- UPDATE 1-Medicines Co's drug improves survival in heart patients
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
